Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease

European Journal of Nuclear Medicine

Volumn 25, Issue 3, 1998, Pages 259-264

  Shreve, Paul D ^a,b,c  

^a Department of Nuclear Medicine ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Division of General Medicine   (United States)

Author keywords

2 Deoxy 2 fluorine 18 fluoro D glucose; Inflammation; Pancreas; Pancreatitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG ACCUMULATION; DRUG UPTAKE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATITIS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031892036     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050226     Document Type: Article

References (14)

1. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192:79-86.
2. Kato T, Fukatsu H, Ito K, et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. Eur J Nucl Med 1995; 22:32-39.
3. Inokuma T, Tamaki N, Torizuka T, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology 1995; 195:345-352.
4. Inokuma T, Tamaki N, Torizuka T. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer. J Nucl Med 1995; 36:229-235.
5. 18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995; 36:771-777.
6. Stollfuss JC, Glatting G, Friess H, Kocher F, Beger HC, Reske SN. 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995; 195:339-344.
7. Zimny M, Bares R, Fass J, et. al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997; 24:678-682.
8. 18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829-831.
9. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35:1647-1649.
10. Neff CC, Simeone JF, Wittenberg J, et al. Pancreatic masses. Radiology 1984; 150:35.
11. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncologic patients. Eur J Nucl Med 1996; 23:1409-1415.
12. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiolgraphy. J Nucl Med 1992; 33:1972-1980.
13. Balthazar E, Ranson J, Naidich D, Megibow A, Caccavale R, Cooper M. Acute pancreatitis: prognostic value of CT. Radiology 1985; 156:767-772.
14. Luetmer PH, Stephens DH, Fischer AP. Obliteration of periarterial retroperitoneal fat on CT in pancreatitis: an exception to the rule. AJR 1989; 153:63-64.